Directors’ Dealings | 25 August 2011 12:28

DGAP-DD: Biotest AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a company of EquityStory AG. The person with duty of notification is solely responsible for the content of this announcement. ————————————————————————— Details of the person subject to the disclosure requirement Last name: Dr. Reinecke First name: Martin Company: Biotest AG Position: Seniour Vice President Plasma Alliances and Protein Supply Information about the transaction with duty of notification Description of the financial instrument: Preference Shares ISIN/WKN of the financial instrument: DE0005227235 Type of transaction: Purchase Date: 25.08.2001 Price: 37.50 Currency: EUR No. of items: 150 Total amount traded: 5625 Place: Stuttgart Information about the company with duty of publication Issuer: Biotest AG Landsteinerstraße 5 63303 Dreieich Deutschland ISIN: DE0005227235 WKN: 522723 End of Directors’ Dealings Notification (c) DGAP 25.08.2011 DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de ID 14102